메뉴 건너뛰기




Volumn 51, Issue 5, 2005, Pages

Post-marketing study to assess the safety, tolerability and effectiveness of Fungisome™: An Indian liposomal amphotericin B preparation

Author keywords

Fungisome ; Liposomal amphotericin B; Post marketing; Systemic fungal infections

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIANEMIC AGENT; CREATININE; FUNGISOME; HYDROCORTISONE; PHENIRAMINE; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

EID: 33645544381     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (20)

References (11)
  • 3
    • 4043151883 scopus 로고    scopus 로고
    • Liposomal Drug Delivery System from laboratory to patients: Our experience
    • Kshirsagar NA, Kirodian BK. Liposomal Drug Delivery System from laboratory to patients: Our experience. Proc. Indian Natn Scie Acad (PINSA) 2002;B68:333-48.
    • (2002) Proc. Indian Natn Scie Acad (PINSA) , vol.B68 , pp. 333-348
    • Kshirsagar, N.A.1    Kirodian, B.K.2
  • 5
    • 0036560408 scopus 로고    scopus 로고
    • In Open label, randomised, comparative Phase III Safety and Efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic Fungal Infection
    • Bodhe PV, Kotwani RN, Kirodian BG, Kshirsagar NA, Pandya SK. In Open label, randomised, comparative Phase III Safety and Efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic Fungal Infection. Jr Assoc Phy Ind 2002;50:662-70
    • (2002) Jr Assoc Phy Ind , vol.50 , pp. 662-670
    • Bodhe, P.V.1    Kotwani, R.N.2    Kirodian, B.G.3    Kshirsagar, N.A.4    Pandya, S.K.5
  • 6
    • 33645538971 scopus 로고
    • New drug application for Phase III clinical studies with liposomal amphotericin B in systemic fungal infections
    • Kshirsagar NA. New drug application for Phase III clinical studies with liposomal amphotericin B in systemic fungal infections, DCGI, India, 1994:17.
    • (1994) DCGI, India , pp. 17
    • Kshirsagar, N.A.1
  • 7
    • 33645534931 scopus 로고    scopus 로고
    • Safety monitoring of medicinal plants
    • The Uppsala Monitoring Centre (the UMC), WHO Collaborating Centre for International Drug Monitoring, Uppsala Sweden
    • Safety monitoring of medicinal plants The Uppsala Monitoring Centre (the UMC), WHO Collaborating Centre for International Drug Monitoring, Stora Torget 3,S-753-20, Uppsala Sweden
    • Stora Torget , vol.3
  • 9
    • 0036177170 scopus 로고    scopus 로고
    • Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients
    • Cargoni PJ. Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Jr Antimicrob Chemo 2002;49:SI81-6.
    • (2002) Jr Antimicrob Chemo , vol.49
    • Cargoni, P.J.1
  • 10
    • 0036180386 scopus 로고    scopus 로고
    • Ambisome in the treatment of fungal infections: The UK experience
    • Chopra R. Ambisome in the treatment of fungal infections: the UK experience. Jr Antimicrob Chemo 2002;49;SI43-7.
    • (2002) Jr Antimicrob Chemo , vol.49
    • Chopra, R.1
  • 11
    • 0031955542 scopus 로고    scopus 로고
    • Liposomal Amphotericin B: Therapeutic use in management of Fungal infections and Visceral leishmaniasis (ADIS Drug Evaluation)
    • Coukell AJ, Brogden RN. Liposomal Amphotericin B: therapeutic use in management of Fungal infections and Visceral leishmaniasis (ADIS Drug Evaluation) Drugs 1998;55:4.
    • (1998) Drugs , vol.55 , pp. 4
    • Coukell, A.J.1    Brogden, R.N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.